Liver transplant for liver cancer
Part of Cancer, Digestive system clinical trials.
This study looks back at patients who had a liver transplant for hepatocellular carcinoma (a type of liver cancer) between 2018 and 2023. It aims to learn more about their outcomes and experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have had a liver transplant between January 1, 2018 and December 31, 2023.
- The transplant must have been performed because of hepatocellular carcinoma (a type of liver cancer).
- Your cancer must have been confirmed by imaging or biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well patients with liver cancer do after receiving a living donor liver transplant that is not the same blood type. It compares survival and cancer return for these patients.
This study is looking at whether a liver transplant can help people who have liver cancer that has spread into the bile ducts, which are the tubes that carry bile from the liver. We want to see if this surgery is safe and how well it works for these patients.
This study tests whether giving a liver transplant to people with cirrhosis and small liver tumors from hepatitis B can help them live longer. It compares outcomes for patients who meet specific tumor size criteria.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
This trial looks at liver transplant for people with advanced intrahepatic cholangiocarcinoma (a bile duct cancer inside the liver) when the cancer is not safely removable and stays controlled. It may help some patients live longer and with better quality of life by replacing the diseased liver—if strict safety and disease-stability requirements are met.
This study combines two surgeries—first removing part of the tumor, then a liver transplant—for patients with advanced liver cancer or liver failure. It aims to offer a chance for cure when standard treatments are not possible.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.